Hansa Biopharma
About
Hansa Biopharma, is a pioneering commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative and life altering treatments for patients with rare immunological conditions. Hansa scientists are working on developing immunomodulatory treatments for organ transplants, rare IgG-mediated autoimmune conditions, and gene therapy, as well as exploring the potential application of the technology platform in oncology.
SE
Scheelevägen 22, Lund
223 63
Public Company
146
Biotechnology Research
Biopharmaceuticals; Clinical development; Drug discovery; In vitro diagnostics; Kidney transplantation; Autoimmune disease; Sepsis; Antibody glycosylation; Orphan drug; Immunomodulatory; Rare diseases
Top Decision Makers · 5
Chief Operating Officer (COO) & President US
Maria Törnsén
United States
******@***.com
Phone
(**) *** ****
Vice President Commercial Europe
Pierre Henri Patin
******@***.com
Phone
(**) *** ****
Chief Executive Officer
Renee Aguiar-Lucander
******@***.com
Phone
(**) *** ****
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles
Find Emails
Access verified email addresses for your target contacts.
657M+ emails
Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers
More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.